India’s first indigenous mRNA vaccine candidate gets DCGI nod for human trial
New Delhi: India's first indigenous mRNA vaccine candidate has received approval from the Drug Controller General of India to initiate Phase I/II human clinical trial, the Ministry of Earth Sciences said Friday. The novel mRNA vaccine candidate, HGCO19 has been developed by Gennova, a company...











































